New York, NY, United States of America

Vincenzo Enea

This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: New York University. Active years: 1990-1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Vincenzo Enea. Retrieved from https://idiyas.com/inventor/vincenzo-enea-ox1eoz58

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

 

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 1990-1997

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Vincenzo Enea: Innovator in Immunogenic Peptides

Introduction

Vincenzo Enea is a notable inventor based in New York, NY (US). He has made significant contributions to the field of immunology, particularly through his work on immunogenic peptides. With a total of 2 patents, Enea's innovations are paving the way for advancements in vaccine development.

Latest Patents

Enea's latest patents include "Immunogenic peptide antigen corresponding to Plasmodium vivax" and "Immunogenic peptide corresponding to P. vivax CS protein." These patents disclose peptides comprising specific amino acids that are crucial for developing effective vaccines against malaria.

Career Highlights

Throughout his career, Vincenzo Enea has worked with prestigious institutions such as New York University and Enzo Biochem, Inc. His work in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Enea has collaborated with notable colleagues, including David E. Arnot and Ruth S. Nussenzweig. These partnerships have enhanced his research and expanded the impact of his inventions.

Conclusion

Vincenzo Enea's contributions to immunogenic peptide research highlight his role as an influential inventor in the field. His patents and collaborations continue to advance the understanding and treatment of malaria.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…